Huayi Quantum announced that it has received CNY 15.5 million in funding from Gaorong Capital, Sequoia China Investment Management LLP, Qiji Chuangtan Investment Management Co., Ltd., Turing Ventures, Aurisco Pharmaceutical Co.,Ltd.
April 22, 2022
Share
Huayi Quantum announced that it has received $15,500,000 in a round of funding led by Gaorong Capital on April 22, 2022. The transaction included participation from , Sequoia China Investment Management LLP, Qiji Chuangtan (Beijing) Investment Management Co., Ltd., Turing Ventures, and Aurisco Pharmaceutical Co.,Ltd.
Aurisco Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of specialty active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The Company's main products are respiratory, cardiovascular, anti-infective and nervous system drugs, including flumethasone, fluticasone propionate, eplerenone, tenofovir, pregabalin and other APIs and intermediates. The Company distributes its products in domestic market and to overseas markets.
Huayi Quantum announced that it has received CNY 15.5 million in funding from Gaorong Capital, Sequoia China Investment Management LLP, Qiji Chuangtan Investment Management Co., Ltd., Turing Ventures, Aurisco Pharmaceutical Co.,Ltd.
AURISCO PHARMACEUTICAL CO.,LTD. 
